Barclays analyst Emily Field maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £15.50.

Teva Pharmaceutical Industries Ltd. ADR-1.19% $20.05B ...

It’s technically you’ll be able to in order to trigger the bonus bullet which have a wild to your all of the 5 reels play 100 Zombies slot, which will make you up to 50 100 percent free spins. However ...

GSK, Sanofi and CSL Ltd have secured $72 million from the US government to ramp up production of bird flu vaccines, Reuters ...

One of the cornerstones of being prepared for the next pandemic is being in the best position possible to design and deploy a ...

Further dampening sentiment on Monday was an order from a U.S. judge for market heavyweight Alphabet's Google to overhaul its ...

Mpox – formerly known as monkeypox – is rapidly spreading in several African countries, prompting the World Health ...

ViiV Healthcare, a GSK-majority-owned HIV specialist, has committed to making at least two million doses of its long-acting ...

Around the world, people are remembering those killed and abducted in Israel last Oct. 7. For Palestinians in Gaza, there is no reprieve from a war that has killed tens of thousands. After days of ...

The War That Won’t End: How Oct. 7 Sparked a Year of Conflict As war in the Middle East spreads, the original conflict between Israel and Hamas has persisted. This is why. 11 min read LIVE ...

GlaxoSmithKline Pharmaceuticals Ltd. key Products/Revenue Segments include Pharmaceuticals, Service Income and Other Operating Revenue for the year ending 31-Mar-2024.For the quarter ended 30-06-2024, ...